Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.7 |
mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | PD-0332991 | FIMM | pan-cancer | AAC | 0.056 | 0.7 |
mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | RITA | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.7 |
mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |